CAPS
Capstone Holding Corp.
NASDAQ · Basic Materials · Construction Materials · US
$2.66
−2.21%Price chart
Sep 21Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20
Key dataOct 20, 2026
Open$2.64
From 52W high−92.49%
Volume38936.00
Market cap$2.44M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 20, 2026
Open
$2.64
From 52W high
−92.49%
Volume
38936.00
Market cap
$2.44M
ValuationView details →
P/E (Fwd)
88.7x
EV/EBITDA
−2.4x
P/E (TTM)
—
RSI (14)
21.3
MomentumView details →
1D Return
−2.21%
YTD Return
−87.68%
SummaryUpdated Jun 1, 2026
Capstone Therapeutics Corp. (NASDAQ:CAPS) is a biotechnology company founded in 1987 and headquartered in Tempe, Arizona. Originally established as OrthoLogic Corp., the company changed its name to Capstone Therapeutics Corp. in May 2010. The company went public in 1993 and has since focused on developing novel peptides and other molecules to address underserved medical conditions. Capstone operates in the competitive biotechnology sector, where companies develop innovative treatments and therapies through extensive research and clinical trials.
Similar companies
Latest newsMore news →
Capstone Holding Corp. reported preliminary organic revenue of $14.0 million for July-August 2026, up 7.6% year over year, with organic gross profit of $3.5 million.20d agoUS prosecutors seized the bank accounts of payments group Capstone, alleging it illegally moved hundreds of millions of dollars for crypto companies at the direction of a Caribbean bank.26d ago